This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Global Blood Therapeutics, Inc.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: DeMei Leung: Innovator in Pharmaceutical Tablets
Introduction
DeMei Leung is a notable inventor based in Los Altos, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative tablet formulations. His work focuses on addressing critical health issues through advanced drug delivery systems.
Latest Patents
Leung holds a patent for "Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde." This patent describes high strength and high drug load tablets that incorporate Compound 1, which is beneficial for treating various hematological disorders, including sickle cell disease, as well as pulmonary diseases like idiopathic pulmonary fibrosis. The tablets also provide methods for treating patients suffering from hypoxia and hypoxemia conditions.
Career Highlights
DeMei Leung is currently associated with Global Blood Therapeutics, Inc., where he continues to innovate in the pharmaceutical sector. His expertise in drug formulation has positioned him as a key player in the development of therapies that improve patient outcomes.
Collaborations
Leung collaborates with talented professionals in his field, including Sean Dalziel and Naveen Bejugam. These partnerships enhance the research and development efforts at Global Blood Therapeutics, Inc.
Conclusion
DeMei Leung's contributions to pharmaceutical innovations, particularly in tablet formulations, demonstrate his commitment to improving healthcare solutions. His work continues to impact the treatment of serious medical conditions, showcasing the importance of innovation in the pharmaceutical industry.